Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension

BACKGROUND: Droxidopa is an orally active prodrug that significantly improved dizziness/lightheadedness measured using the Orthostatic Hypotension Symptom Assessment (OHSA) Item 1 in patients with neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson disease, multip...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Clément, Rowse, Gerald J., Hewitt, L. Arthur, Vo, Pamela, Hauser, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990877/
https://www.ncbi.nlm.nih.gov/pubmed/27538531
http://dx.doi.org/10.1186/s12883-016-0665-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990877/
https://www.ncbi.nlm.nih.gov/pubmed/27538531
http://dx.doi.org/10.1186/s12883-016-0665-5

Ejemplares similares